Why is Olympus Corp. ?
- The company has declared negative results in Jan 70 after 3 consecutive negative quarters
- DEBT-EQUITY RATIO (HY) Highest at 4.23 %
- INTEREST(Q) At JPY 1,156 MM has Grown at 112.5%
- NET PROFIT(Q) At JPY 8,991 MM has Fallen at -50.52%
- Along with generating -15.03% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Olympus Corp. for you?
Medium Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at JPY 152,003 MM
Fallen by 1.66% (YoY
Highest at 4.23 %
At JPY 1,156 MM has Grown at 112.5%
At JPY 8,991 MM has Fallen at -50.52%
Lowest at 1.56%
Lowest at JPY 206,512 MM
Lowest at JPY 29,156 MM
Lowest at 14.12 %
Lowest at JPY 16,640 MM
Lowest at JPY 7.96
Here's what is working for Olympus Corp.
Operating Cash Flows (JPY MM)
Raw Material Cost as a percentage of Sales
Here's what is not working for Olympus Corp.
Interest Paid (JPY MM)
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Debt-Equity Ratio
Net Sales (JPY MM)
Net Sales (JPY MM)
Operating Profit (JPY MM)
Operating Profit to Sales
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Inventory Turnover Ratio






